Stockreport

Erasca to Present at the Guggenheim Securities SMID Cap Biotech Conference

Erasca, Inc.  (ERAS) 
PDF SAN DIEGO, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, an [Read more]